According to the Robert Koch Institute (RKI), the norovirus, which is widespread worldwide, is the cause of a large proportion of gastrointestinal infections. Those who catch the virus suffer from nausea, diarrhea and vomiting. It is very contagious and can spread quickly from person to person.
There is not much that can be done preventively beyond general hygiene rules. There is currently no vaccine against the norovirus. However, doctors have now begun to test the world’s first mRNA vaccine against the norovirus.
Norovirus vaccine based on mRNA technology is being tested
The vaccine is to undergo a phase three clinical trial called Nova 301. In two years, 25,000 people, mainly over 60 years old, from countries such as Japan, Canada and Australia are to be involved, reports the Guardian. Mobile teams are also to be used to make it easier for people to participate in the trial.
Half of the participants are to receive the new mRNA vaccine and the other half a saline solution as a placebo. The assignment follows at random.
Various institutions of the British National Health Service (NHS) and the pharmaceutical company Moderna, which manufactures the vaccine, are involved in the study. The norovirus vaccine is based on an mRNA technology with which the company Moderna, but also Pizer/Biontech, have already produced a vaccine against the corona virus.
In an earlier trial with the new norovirus vaccine, strong immune reactions are said to have already been detected in humans. The study is now about investigating whether the vaccine is effective against the virus itself and, if so, how long the protection lasts. “At least 65 percent (efficacy) or more is what we would consider clinically sensible,” the Guardian quotes Dr. Doran Fink of Moderna.
Norovirus is a threat to old and sick people
Norovirus outbreaks are common in hospitals, nursing homes, daycare centers or schools. Especially for very young or old people and for anyone who has a weakened immune system, an infection can have serious consequences. A successful vaccine would help ensure that operations in nursing homes could be maintained normally, says Prof. Saul Faust of the University of Southampton, according to the report.
General practitioner and study leader Dr. Patrick Moore emphasizes how high the burden of norovirus is. Worldwide, there are about 685 million cases and 200,000 deaths every year. In the UK, there are about four million cases a year.
It is hoped that a vaccine could bring health and economic benefits. “In the UK, norovirus costs the NHS an estimated £100 million a year [and] if you take into account the loss of earnings, it’s about £300 million,” says Moore.
If the result of the study is positive, it is expected that it will be possible to submit an application for approval for the vaccine in 2026. However, the review process would take another up to a year. In addition, further studies on teenagers and younger people would be needed.

News
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]